Showing results (61-70 of 237) with videos related to
Sort By:
Pageof 24
Pediatric Hematology and Oncology|May 3, 2022
Views of IRB members regarding phase 1 pediatric oncology trialsDavid Wendler, Will Schupmann, Xiaobai LiJournal of Pediatric Hematology/Oncology|November 8, 2008
How do children and parents make decisions about pediatric clinical research?Sumeeta Varma, Tammara Jenkins, David WendlerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
The ethics of phase 0 oncology trialsEmily Abdoler, Holly Taylor, David WendlerThe American Journal of Psychiatry|December 7, 2005
Research advance directives: protection or obstacle?Palaniappan Muthappan, Heidi Forster, David WendlerCritical Care Medicine|November 11, 2024
The Need for Institutional Policies for Innovative Therapy: Existing Approaches and Key ElementsEmily Rao, Christine Grady, David WendlerWellcome Open Research|July 6, 2023
Consent, decisional capacity and guardianship in mental health researchJuan Undurraga, Hanna Negussie, David WendlerThe Journal of Pediatrics|June 18, 2021
Do the Potential Medical Benefits of Phase 1 Pediatric Oncology Trials Justify the Risks? Views of the United States PublicWill Schupmann, Xiaobai Li, David WendlerJournal of the American Geriatrics Society|April 4, 2012
Systematic review: Individuals' goals for surrogate decision-makingBrenna Kelly, Annette Rid, David WendlerPediatric Blood & Cancer|April 24, 2012
Shared medical decision-making: considering what options to present based on an ethical analysis of the treatment of brain tumors in very young childrenDeena Levine, Kenneth Cohen, David WendlerBioethics|May 26, 2010
Which benefits of research participation count as 'direct'?Alexander Friedman, Emily Robbins, David WendlerPageof 24